Prediction of metastatic status in non-seminomatous testicular cancer
- 29 October 2013
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 32 (5) , 1205-1211
Abstract
To examine the significance of 90 biomarkers for predicting metastatic status in non-seminomatous germ cell tumors (NSGCT). By predicting metastatic status, it may be possible to eliminate unnecessary therapeutic or diagnostic efforts.Keywords
This publication has 30 references indexed in Scilit:
- 703 CIRCULATING TUMOR CELLS CAN BE DETECTED IN PATIENTS WITH TESTICULAR GERM CELL TUMORSJournal of Urology, 2013
- Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancerAnnals of Oncology, 2012
- Surveillance in stage I nonseminomatous germ cell tumours of the testisBJU International, 2009
- European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part IEuropean Urology, 2008
- Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC TrialsEuropean Urology, 2006
- Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular CancerJournal of Clinical Oncology, 2006
- Paternity Following Treatment for Testicular CancerJNCI: Journal of the National Cancer Institute, 2005
- The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular CancerJournal of Clinical Oncology, 2005
- Predictors of Occult Metastasis in Clinical Stage I Nonseminoma: A Systematic ReviewJournal of Clinical Oncology, 2003
- Surveillance following orchidectomy for stage I seminoma of the testisEuropean Journal of Cancer, 1993